Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GPI-anchored alkaline phosphatase (ALP), specifically the ALP1 isoform, is a membrane-bound enzyme predominantly expressed in the midgut epithelium of mosquito larvae, such as Aedes aegypti (Fernandez et al., 2006; Jimenez et al., 2012). It functions physiologically in the hydrolysis of phosphate esters and the transport of nutrients across the midgut membrane (Stalinski et al., 2016). In the field of vector control, this protein is highly significant as a primary functional receptor for the Cry toxins produced by Bacillus thuringiensis subsp. israelensis (Bti), including Cry11Aa and Cry4Ba (Likitvivatanavong et al., 2011). The interaction between these toxins and ALP is a critical step in the toxins' mechanism of action, where binding triggers toxin oligomerization and the formation of lethal pores in the larval midgut cells (Fernandez et al., 2006; Jimenez et al., 2012). This process leads to the destruction of the gut lining and the eventual death of the mosquito larvae (Lee et al., 2014). Due to its essential role in toxin-mediated mortality, ALP is a major focus for developing biopesticides and monitoring insecticide resistance in mosquito populations (Stalinski et al., 2016).
Binding of Cry toxins to the receptor facilitates toxin oligomerization, membrane insertion, and pore formation in midgut epithelial cells, leading to cell lysis and larval death.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alkaline phosphatase 1 (ALP1).